Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octenidine dihydrochloride for Preoperative Skin Preparation
NCT03224299Phase 2Completed
- Sponsor
- BD
- Start
- Jun 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of octenidine in surgical site infection (SSI), sponsored by BD. Started Jun 2017; status: completed.
02
Drugs
octenidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03224299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03224299.